Hautarztpraxis Dr. Med. Matthias Hoffmann
- Address
- Annenstrasse 151, Annen, North Rhine-Westphalia, 58453 Witten, Germany
Palmoplantar Pustulosis
The clinic in Witten is conducting research on palmoplantar pustulosis, a chronic skin disorder affecting the soles and palms. A study compares a new topical JAK inhibitor cream with a standard vehicle to determine its effectiveness in adult patients.
- Topical JAK inhibition as a novel approach
- Improvement in pain and lesion clearance
- Safety and tolerability during prolonged use
The goal is to offer a convenient, non‑systemic treatment option that can reduce symptoms and enhance daily functioning for those with mild to severe disease.
Nummular Dermatitis
At Hautarztpraxis Dr. Med. Matthias Hoffmann, investigators are evaluating lebrikizumab, a biologic agent, for patients with nummular dermatitis whose condition is not adequately managed with topical corticosteroids.
- Targeting the interleukin‑13 pathway
- Efficacy in steroid‑refractory eczema
- Monitoring long‑term safety outcomes
This research aims to broaden therapeutic choices and improve skin health for individuals struggling with persistent, itchy patches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Almirall S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Dr. Med. Matthias Hoffmann
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Delgocitinib Cream Versus Vehicle in Adult Patients with Mild to Severe Palmoplantar Pustulosis: A Phase 2a, Double-Blind Trial | Leo Pharma A/S | Phase II | Recruiting | Aug 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lebrikizumab | 1 | Unknown | 2026-04-10 | 2026-04-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.